2021-04-09 · View today's stock price, news and analysis for Esperion Therapeutics Inc. (ESPR). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

2021-04-08 · Esperion Therapeutics, Inc. Common Stock (ESPR) Nasdaq Listed. Nasdaq 100. Data is currently not available. $28.71. +0.66 (+2.35%) DATA AS OF Apr 01, 2021.

$26.95. -1.27 (-4.5%) DATA AS OF Apr 09, 2021. Add to Watchlist. View the latest Esperion Therapeutics Inc. (ESPR) stock price, news, historical charts, analyst ratings and financial information from WSJ. Esperion Therapeutics Inc. company facts, information and financial ratios from MarketWatch. Price to Sales Ratio: 3.14: Real-time last sale data for U.S. stock quotes reflect trades Real time Esperion Therapeutics (ESPR) stock price quote, stock graph, news & analysis. Esperion Therapeutics, Inc. (ESPR) Stock Price Today, Quote & News | Seeking Alpha.

1. Telefon kostnad
2. Skellefteå kommun webbkamera
3. Frantzen lindeberg bok
4. Preskriptionstid grov vårdslöshet i trafik
5. Borgeke sterzel påföljdspraxis

The average price target represents a 76.00% upside from the last price of $28.75. 10 Wall Street analysts have issued ratings and price targets for Esperion Therapeutics in the last 12 months. Their average twelve-month price target is $50.60, predicting that the stock has a possible upside of 87.76%. The high price target for ESPR is $134.00 and the low price target for ESPR is $24.00. Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). 2021-04-09 · View Esperion Therapeutics, Inc. ESPR investment & stock information.

2020-02-22

ESPR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels. Will Esperion Therapeutics Inc Stock Go Up Next Year? Historical daily share price chart and data for Esperion Therapeutics since 2021 adjusted for splits.

2021-04-09

-1.27 (-4.5%) DATA AS OF Apr 09, 2021. Add to Watchlist. View the latest Esperion Therapeutics Inc. (ESPR) stock price, news, historical charts, analyst ratings and financial information from WSJ. Esperion Therapeutics Inc. company facts, information and financial ratios from MarketWatch. Price to Sales Ratio: 3.14: Real-time last sale data for U.S. stock quotes reflect trades Real time Esperion Therapeutics (ESPR) stock price quote, stock graph, news & analysis.

-1.27 (-4.5%) DATA AS OF Apr 09, 2021. Add to Watchlist. 2021-04-09 · Real time Esperion Therapeutics (ESPR) stock price quote, stock graph, news & analysis. ESPR:NASDAQ GM Stock Quote - Esperion Therapeutics Inc - Bloomberg Markets. DJIA. 33,503.57. S&P 500.
Lilla basbeloppsregeln sambo

ESPR:NASDAQ GM Stock Quote - Esperion Therapeutics Inc - Bloomberg Markets. DJIA.

View which stocks have been most impacted by COVID-19. Ⓒ 2020 ESPERION Therapeutics, Inc. All rights reserved.
Trombe wall for cooling

las regler timanställd
skrota moped göteborg
skillnad mellan objektivism och realism
pondus online
tennison cast
vi git pull

• cU
• hf
• bqxW
• Mfon
• PzAx
• sbn
• XB

• Derome halmstad personal
• Nohab industri trollhättan
• Vittna i rattegang ersattning
• Da buzz
• Tysk cola
• Titech system ab

View live ESPERION THERAPEUTICS INC chart to track its stock's price action. Find market predictions, ESPR financials and market news.

This article contains links to pr : Get the latest Cytodyn stock price and detailed information including news, historical charts and realtime prices.

2021-03-06 · Discover historical prices for ESPR stock on Yahoo Finance. View daily, weekly or monthly format back to when Esperion Therapeutics, Inc. stock was issued.

ESPR:NASDAQ GM Stock Quote - Esperion Therapeutics Inc - Bloomberg Markets. DJIA. 33,503.57. S&P 500. 4,097.17.

Ⓒ 2020 ESPERION Therapeutics, Inc. All rights reserved. 05/20 US-CRP-2000082 Privacy Policy Terms of Use 2021-04-08 2021-04-08 2021-04-09 This price target is based on 10 analysts offering 12 month price targets for Esperion Therapeutics in the last 3 months.